Logo image of ALBFR.PA

SIDETRADE (ALBFR.PA) Stock Fundamental Analysis

Europe - EPA:ALBFR - FR0010202606 - Common Stock

206 EUR
0 (0%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

6

ALBFR gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 102 industry peers in the Software industry. ALBFR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ALBFR is valued quite expensively, but it does show have an excellent growth rating. These ratings would make ALBFR suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

ALBFR had positive earnings in the past year.
ALBFR had a positive operating cash flow in the past year.
Each year in the past 5 years ALBFR has been profitable.
ALBFR had a positive operating cash flow in each of the past 5 years.
ALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

ALBFR's Return On Assets of 10.30% is amongst the best of the industry. ALBFR outperforms 84.31% of its industry peers.
ALBFR has a Return On Equity of 20.04%. This is amongst the best in the industry. ALBFR outperforms 81.37% of its industry peers.
The Return On Invested Capital of ALBFR (8.78%) is better than 67.65% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALBFR is below the industry average of 12.69%.
The 3 year average ROIC (8.57%) for ALBFR is below the current ROIC(8.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.3%
ROE 20.04%
ROIC 8.78%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ALBFR.PA Yearly ROA, ROE, ROICALBFR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of ALBFR (14.36%) is better than 65.69% of its industry peers.
In the last couple of years the Profit Margin of ALBFR has grown nicely.
Looking at the Operating Margin, with a value of 10.56%, ALBFR is in the better half of the industry, outperforming 60.78% of the companies in the same industry.
ALBFR's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 75.67%, ALBFR is in line with its industry, outperforming 58.82% of the companies in the same industry.
In the last couple of years the Gross Margin of ALBFR has grown nicely.
Industry RankSector Rank
OM 10.56%
PM (TTM) 14.36%
GM 75.67%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
ALBFR.PA Yearly Profit, Operating, Gross MarginsALBFR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALBFR is creating some value.
Compared to 1 year ago, ALBFR has more shares outstanding
Compared to 5 years ago, ALBFR has more shares outstanding
ALBFR has a better debt/assets ratio than last year.
ALBFR.PA Yearly Shares OutstandingALBFR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALBFR.PA Yearly Total Debt VS Total AssetsALBFR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ALBFR has an Altman-Z score of 6.90. This indicates that ALBFR is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.90, ALBFR is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
The Debt to FCF ratio of ALBFR is 0.92, which is an excellent value as it means it would take ALBFR, only 0.92 years of fcf income to pay off all of its debts.
ALBFR has a Debt to FCF ratio of 0.92. This is amongst the best in the industry. ALBFR outperforms 80.39% of its industry peers.
ALBFR has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.20, ALBFR is in the better half of the industry, outperforming 62.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.92
Altman-Z 6.9
ROIC/WACC1.08
WACC8.1%
ALBFR.PA Yearly LT Debt VS Equity VS FCFALBFR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

ALBFR has a Current Ratio of 1.55. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
ALBFR's Current ratio of 1.55 is fine compared to the rest of the industry. ALBFR outperforms 60.78% of its industry peers.
ALBFR has a Quick Ratio of 1.55. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.55, ALBFR is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.55
ALBFR.PA Yearly Current Assets VS Current LiabilitesALBFR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.62% over the past year.
ALBFR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 27.85% yearly.
Looking at the last year, ALBFR shows a very strong growth in Revenue. The Revenue has grown by 25.69%.
The Revenue has been growing by 16.43% on average over the past years. This is quite good.
EPS 1Y (TTM)40.62%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%22.96%
Revenue 1Y (TTM)25.69%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%31.95%

3.2 Future

Based on estimates for the next years, ALBFR will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.26% on average per year.
ALBFR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.57% yearly.
EPS Next Y10.08%
EPS Next 2Y11.31%
EPS Next 3Y11.26%
EPS Next 5YN/A
Revenue Next Year10.68%
Revenue Next 2Y11.19%
Revenue Next 3Y11.57%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALBFR.PA Yearly Revenue VS EstimatesALBFR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALBFR.PA Yearly EPS VS EstimatesALBFR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ALBFR is valuated quite expensively with a Price/Earnings ratio of 39.62.
62.75% of the companies in the same industry are more expensive than ALBFR, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.30. ALBFR is valued slightly more expensive when compared to this.
ALBFR is valuated quite expensively with a Price/Forward Earnings ratio of 34.87.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALBFR is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.73. ALBFR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 39.62
Fwd PE 34.87
ALBFR.PA Price Earnings VS Forward Price EarningsALBFR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

ALBFR's Enterprise Value to EBITDA is on the same level as the industry average.
ALBFR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ALBFR is cheaper than 62.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 36.07
EV/EBITDA 40.44
ALBFR.PA Per share dataALBFR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of ALBFR may justify a higher PE ratio.
PEG (NY)3.93
PEG (5Y)1.42
EPS Next 2Y11.31%
EPS Next 3Y11.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALBFR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIDETRADE

EPA:ALBFR (9/12/2025, 7:00:00 PM)

206

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-15 2025-04-15
Earnings (Next)09-17 2025-09-17
Inst Owners18.26%
Inst Owner ChangeN/A
Ins Owners35.29%
Ins Owner ChangeN/A
Market Cap309.00M
Analysts84
Price Target290.7 (41.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.43%
EPS NY rev (3m)-0.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.79%
Valuation
Industry RankSector Rank
PE 39.62
Fwd PE 34.87
P/S 5.62
P/FCF 36.07
P/OCF 32.3
P/B 7.84
P/tB 35.81
EV/EBITDA 40.44
EPS(TTM)5.2
EY2.52%
EPS(NY)5.91
Fwd EY2.87%
FCF(TTM)5.71
FCFY2.77%
OCF(TTM)6.38
OCFY3.1%
SpS36.65
BVpS26.27
TBVpS5.75
PEG (NY)3.93
PEG (5Y)1.42
Profitability
Industry RankSector Rank
ROA 10.3%
ROE 20.04%
ROCE 11.95%
ROIC 8.78%
ROICexc 18.16%
ROICexgc N/A
OM 10.56%
PM (TTM) 14.36%
GM 75.67%
FCFM 15.58%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ROICexc(3y)18.44%
ROICexc(5y)20.75%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.66%
ROCE(5y)12.74%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-1.75%
ROICexc growth 5Y5.4%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.92
Debt/EBITDA 1.09
Cap/Depr 71.02%
Cap/Sales 1.82%
Interest Coverage 250
Cash Conversion 132.6%
Profit Quality 108.49%
Current Ratio 1.55
Quick Ratio 1.55
Altman-Z 6.9
F-Score7
WACC8.1%
ROIC/WACC1.08
Cap/Depr(3y)191.5%
Cap/Depr(5y)202.1%
Cap/Sales(3y)4.08%
Cap/Sales(5y)4.13%
Profit Quality(3y)97.77%
Profit Quality(5y)121.95%
High Growth Momentum
Growth
EPS 1Y (TTM)40.62%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%22.96%
EPS Next Y10.08%
EPS Next 2Y11.31%
EPS Next 3Y11.26%
EPS Next 5YN/A
Revenue 1Y (TTM)25.69%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%31.95%
Revenue Next Year10.68%
Revenue Next 2Y11.19%
Revenue Next 3Y11.57%
Revenue Next 5YN/A
EBIT growth 1Y-0.02%
EBIT growth 3Y5.13%
EBIT growth 5Y20.49%
EBIT Next Year2.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.61%
FCF growth 3Y12.94%
FCF growth 5Y37.14%
OCF growth 1Y10%
OCF growth 3Y9.02%
OCF growth 5Y29.8%